𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

✍ Scribed by Kriege, M; Hollestelle, A; Jager, A; Huijts, P E A; Berns, E M; Sieuwerts, A M; Meijer-van Gelder, M E; Collée, J M; Devilee, P; Hooning, M J; Martens, J W M; Seynaeve, C

Book ID
125543929
Publisher
Nature Publishing Group
Year
2014
Tongue
English
Weight
393 KB
Volume
111
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHEK2*1100delC and male breast cancer ri
CHEK2*1100delC and male breast cancer risk in Israel
✍ Tal Ohayon; Inbar Gal; Ruth Gershoni Baruch; Csilla Szabo; Eitan Friedman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 49 KB

## Dear Sir, Fewer than 1% of all breast cancers occur in males. 1 Known risk factors for male breast cancer primarily include Klinefelter syndrome and other clinical conditions associated with aberrant hormonal status (e.g., benign breast disease and gynecomastia, liver cirrhosis, estrogen therap